Recruitment for Pharmaceutical Assessors
Published By GOV.UK [English], Wed, Jan 26, 2022 8:11 AM
These exciting and interesting jobs put you at the heart of authorising animal medicines for the UK market.
You will assess quality data submitted in support of applications for the authorisation of pharmaceutical products and play a major role in assuring the quality and hence the safety and efficacy of animal medicines. You may manage and develop quality assessors in the Quality Team.
You will also contribute to the review and development of regulatory and scientific guidelines aimed at the pharmaceutical industry, contribute to the VMD’s Regulatory Science Strategy and play a significant role in the VMD`s international activities.
This work will significantly contribute to the VMD meeting its published standards.
Job Title
Pharmaceutical Assessor in the Pharmaceuticals/Quality Team
Grade
Grade 7
Salary
£52,289 - £60,188 per annum & Pension Scheme
Annual Leave entitlement
Commencing at 25 days
Regulatory Science Strategy and Guideline development role:
lead the Quality Team’s contribution to the VMD’s Regulatory Science Strategy and
lead the Quality Team’s contribution to developing scientific and regulatory industry guidance for pharmaceutical veterinary medicinal products
VMD international work role:
lead the co-ordination of the Quality Team’s contribution to VMD International Strategy activities
The main role of the team is to:
assess quality data submitted by companies in support of their applications for new marketing authorisations for veterinary medicines
consider applications to renew or vary existing authorisations
consider applications to conduct clinical trials and to deal with applications for feed additive must have a degree or equivalent in pharmacy, pharmaceutical science, chemistry or other relevant subject.
How to apply
Pharmaceutical Assessors in the Pharmaceuticals/Quality Team - Civil Service Jobs - GOV.UK
Closing Date 7 February 2022
Press release distributed by Media Pigeon on behalf of GOV.UK, on Jan 26, 2022. For more information subscribe and follow